Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scheinberg

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Cell Reports|August 19, 2014
Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancerJennifer C Villa, Danica Chiu, Alissa H Brandes, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Cancer Immunology Research|June 28, 2023
Host Interactions with Engineered T-cell MicropharmaciesChristopher M Bourne, Patrick Wallisch, Megan M Dacek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
JCI Insight|March 9, 2022
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complexTao Dao, Sung Soo Mun, Zaki Molvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoproteinNicholas Veomett, Tao Dao, Hong Liu, et al.
Blood Advances|August 19, 2022
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemiaDanielle C Kirkey, Anisha M Loeb, Sommer Castro, et al.
Cancer Cell|February 28, 2025
Metabolic engineering to facilitate anti-tumor immunityTanya Schild, Patrick Wallisch, Yixuan Zhao, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Cell Reports|August 19, 2014
Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancerJennifer C Villa, Danica Chiu, Alissa H Brandes, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Cancer Immunology Research|June 28, 2023
Host Interactions with Engineered T-cell MicropharmaciesChristopher M Bourne, Patrick Wallisch, Megan M Dacek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
JCI Insight|March 9, 2022
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complexTao Dao, Sung Soo Mun, Zaki Molvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoproteinNicholas Veomett, Tao Dao, Hong Liu, et al.
Blood Advances|August 19, 2022
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemiaDanielle C Kirkey, Anisha M Loeb, Sommer Castro, et al.
Cancer Cell|February 28, 2025
Metabolic engineering to facilitate anti-tumor immunityTanya Schild, Patrick Wallisch, Yixuan Zhao, et al.
Pageof 17